Advertisement

Topics

Using CRISPR-Cas Screens to Reveal Fitness Genes and to Map Genetic Interactions, New Webinar Hosted by Xtalks

12:45 EST 14 Jan 2019 | PR Web

Genomic analyses are yielding a host of new information on the multiple genetic abnormalities associated with specific types of cancer. A comprehensive description of cancer-associated genetic abnormalities can improve our ability to classify tumors into clinically relevant subgroups and sometimes identify drivers. In this webinar, learn how the Moffat lab’s screening workflow helps to discern the functional significance of cancer-associated mutations.

TORONTO (PRWEB) January 14, 2019

Forward genetic screens provide a powerful tool to identify genes or genetic networks that contribute to specific biological phenotypes or diseases and therefore hold great potential for elucidating gene function and revealing therapeutic targets for diseases. The advent of CRISPR-Cas technology has revolutionized genome editing in higher eukaryotes and enables efficient gene manipulation in mammalian cells. CRISPR guide-RNA libraries allow facile generation of a pool of genetically perturbed cells and its application in genetic screens has marked a major breakthrough for functional genomics in mammalian cells.

Using genome wide CRISPR-Cas9 knockout libraries, the Moffat Lab has screened various human cell lines to reveal a set of core fitness genes required to sustain proliferation, and context-dependent fitness genes that are essential only in a specific genotype uncovering novel genetic dependencies. Accompanying these screens, the Moffat Lab has developed statistical scoring algorithms like the Bayesian Analysis of Gene Essentiality (“BAGEL”) to identify fitness genes, as well as gold standard reference gene sets that allow us validate screening performance. Using an optimized screening workflow, they are currently applying CRISPR-Cas9 technology to construct a genetic interaction network for a reference human cell line (HAP1) for functional annotation of the human genome based on mutant query screens.

Join Michael Aregger, PhD and Keith Lawson, MD – from the Moffat lab at the University of Toronto, in a live session on Thursday, February 7, 2019 at 11am EST (4pm GMT) to learn:

  • How to design and perform genome-wide pooled CRISPR screens in mammalian cells
  • To use the gold standard essential and non-essential reference gene sets to control screen performance
  • Experimental approaches to reveal genetic interactions in isogenic CRISPR modified human cells lines

For more information or to register for this event, visit Using CRISPR-Cas Screens to Reveal Fitness Genes and to Map Genetic Interactions.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

For the original version on PRWeb visit: https://www.prweb.com/releases/using_crispr_cas_screens_to_reveal_fitness_genes_and_to_map_genetic_interactions_new_webinar_hosted_by_xtalks/prweb16030187.htm

NEXT ARTICLE

More From BioPortfolio on "Using CRISPR-Cas Screens to Reveal Fitness Genes and to Map Genetic Interactions, New Webinar Hosted by Xtalks"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...